Public Reports

The following reports are published by the DMHC and made available to the public.

Timely Access Report

The Timely Access Report summarizes provider appointment availability data that health plans submitted to the DMHC. The charts within this report show provider responses to appointment availability requests. 

Measurement Year 2019

Measurement Year 2018

Measurement Year 2017

Measurement Year 2016

Measurement Year 2015

Measurement Year 2014

Prescription Drug Cost Transparency Report

Senate Bill (SB) 17 (2017) requires health plans and health insurers that file rate information with the DMHC or the California Department of Insurance (CDI) to annually report specific information related to the costs of covered prescription drugs. This report looks at the impact of the cost of prescription drugs on health plan premiums in the commercial market.

Measurement Year 2019

Measurement Year 2018

Measurement Year 2017

Large Group Aggregate Rates and Prescription Drug Cost Transparency

SB 546 (2015) requires health plans to submit aggregate rate information for products in the large group market. In addition, SB 17 (2017) requires health plans to submit specific prescription drug cost information. The report looks at the reasons for changes in the rates, benefits, and cost sharing in the large group market as well as prescription drug costs on health plan premiums.

Measurement Year 2020

Measurement Year 2019

Measurement Year 2018

Measurement Year 2017

Measurement Year 2016